Pacira Pharmaceuticals buy HC Wainwright
Start price
04.03.24
/
50%
€26.20
Target price
04.03.25
€52.53
Performance (%)
-46.56%
Price
02.09.24
€13.80
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright for Pacira Pharmaceuticals is performing very badly with a performance of -46.56%. This prediction currently runs until 04.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 7.813% | 7.813% |
iShares Core DAX® | 1.663% | 6.945% |
iShares Nasdaq 100 | 1.261% | 4.883% |
iShares Nikkei 225® | 0.654% | 10.007% |
iShares S&P 500 | 1.403% | 4.350% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.07.24
02.07.24
€53.05
02.07.25
02.07.25
-33.49%
02.09.24
02.09.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
-47.39%
02.09.24
02.09.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
-50.35%
02.09.24
02.09.24